Aviv Healthcare Limited 14735295 false 2023-03-16 2024-03-31 2024-03-31 The principal activity of the company is health activities Digita Accounts Production Advanced 6.30.9574.0 true true 14735295 2023-03-16 2024-03-31 14735295 2024-03-31 14735295 bus:OrdinaryShareClass1 2024-03-31 14735295 core:RetainedEarningsAccumulatedLosses 2024-03-31 14735295 core:ShareCapital 2024-03-31 14735295 core:CurrentFinancialInstruments 2024-03-31 14735295 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14735295 bus:SmallEntities 2023-03-16 2024-03-31 14735295 bus:AuditExemptWithAccountantsReport 2023-03-16 2024-03-31 14735295 bus:FilletedAccounts 2023-03-16 2024-03-31 14735295 bus:SmallCompaniesRegimeForAccounts 2023-03-16 2024-03-31 14735295 bus:RegisteredOffice 2023-03-16 2024-03-31 14735295 bus:Director1 2023-03-16 2024-03-31 14735295 bus:Director2 2023-03-16 2024-03-31 14735295 bus:OrdinaryShareClass1 2023-03-16 2024-03-31 14735295 bus:PrivateLimitedCompanyLtd 2023-03-16 2024-03-31 14735295 countries:EnglandWales 2023-03-16 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14735295

Aviv Healthcare Limited

Unaudited Filleted Financial Statements

for the Period from 16 March 2023 to 31 March 2024

 

Aviv Healthcare Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Aviv Healthcare Limited

Company Information

Directors

Ms R Mbabazi

Mr B Mavurah

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Aviv Healthcare Limited

(Registration number: 14735295)
Balance Sheet as at 31 March 2024

Note

2024
£

Current assets

 

Debtors

4

2,351

Cash at bank and in hand

 

198

 

2,549

Creditors: Amounts falling due within one year

5

(70,388)

Net liabilities

 

(67,839)

Capital and reserves

 

Called up share capital

6

100

Retained earnings

(67,939)

Shareholders' deficit

 

(67,839)

For the financial period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 11 March 2025 and signed on its behalf by:
 

.........................................
Mr B Mavurah
Director

 

Aviv Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 16 March 2023 to 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

These financial statements were authorised for issue by the Board on 11 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Aviv Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 16 March 2023 to 31 March 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 3.

4

Debtors

Current

2024
£

Other debtors

2,351

 

2,351

 

Aviv Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 16 March 2023 to 31 March 2024

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

Due within one year

 

Trade creditors

 

3,921

Amounts owed to group undertakings and undertakings in which the company has a participating interest

53,160

Taxation and social security

 

5,649

Accruals and deferred income

 

2,500

Other creditors

 

5,158

 

70,388

 

Aviv Healthcare Limited

Notes to the Unaudited Financial Statements for the Period from 16 March 2023 to 31 March 2024

6

Share capital

Allotted, called up and fully paid shares

2024

No.

£

Ordinary of £1 each

100

100